Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
NewAmsterdam Pharma (NASDAQ:NAMS) Issues Earnings Results
NewAmsterdam Pharma (NASDAQ:NAMS - Get Free Report) issued its earnings results on Thursday. The company reported ($0.40) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.46) by $0.06, FiscalAI reports. The company…
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Given Consensus Recommendation of 'Moderate Buy' by Brokerages
Shares of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) have been given a consensus recommendation of 'Moderate Buy' by the twelve analysts that are currently covering the firm, MarketBeat.com reports. One research analyst has…
UBS Group AG Raises Stock Position in NewAmsterdam Pharma Company N.V. $NAMS
UBS Group AG increased its stake in NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Free Report) by 17.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 899,442 shares of…
A Member of Sackler Family Says She Got Addicted to Opioids
Can't-miss innovations from the bleeding edge of science and tech The opioid crisis seems to be coming full circle. As the Sackler family negotiated to pay a $6.5 billion settlement over their role in Purdue Pharma's production of addictive…
Trump responds to reports FDA chief Mark Makary could be fired: 'Know nothing about it
President Donald Trump downplayed reports that he was getting ready to fire Food and Drug Administration (FDA) Commissioner Marty Makary while speaking to reporters Friday. 'I've been reading about it, but I know nothing about it,' Trump said in…
Want to ride market volatility? Edelweiss Aggressive Hybrid Fund is a smart choice
Edelweiss Aggressive Hybrid Fund has established itself as one of the consistent performers in the aggressive hybrid fund category. Since becoming eligible for bl.portfolio's Star Track ratings, the scheme has maintained either a four-star or…
Maravai (MRVI) Q1 2026 Earnings Transcript
Chief Executive Officer — Bernd Brust Chief Financial Officer — Rajesh Asarpota Chief Scientific Officer — Chanfeng Zhao Investor Relations — Debra Hart Need a quote from a Motley Fool analyst? Email [email protected]…
GP du Morbihan: Benoît Cosnefroy scores fourth victory at French one-dayer
Benoît Cosnefroy (UAE Team Emirates-XRG) sped to his fourth career victory at the GP du Morbihan and his third in a row, beating the Decathlon-CMA CGM duo of Noa Isidore and Paul Lapeira to the finish line in Plumelec. The Frenchman's 22nd…
Top Growth Stocks To Keep An Eye On - May 9th
Prologis Q1 2026: Data Centers Steal the Show Prologis, Ascendis Pharma A/S, and Teledyne Technologies are the three Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies expected to…
Trump responds to reports FDA chief Mark Makary could be fired: 'Know nothing about it'
NEWYou can now listen to Fox News articles! President Donald Trump downplayed reports that he was getting ready to fire Food and Drug Administration (FDA) Commissioner Marty Makary while speaking to reporters Friday. “I've been reading about…
The progressive plan to reclaim the working class
For years, one of the bedrock adages of electoral politics was “it's the economy, stupid.” The quip, coined by former Bill Clinton strategist James Carville, warned party leaders that economic concerns will always outrank other issues…
Plymouth City Council needs to improve its ambitions
Some of the latest reader letters in our sister print title The Herald touch on triple lock pensions, the ambitiousness of the current city council and more. Get in touch - tell us what you think. You can comment below or email to be featured. Our…
Everus Construction Group Q1 Earnings Call Highlights
Mid-Cap Marvels: 3 Stocks That Crushed Sales Estimates in May Everus Construction Group NYSE: ECG reported a strong start to 2026, with first-quarter revenue and EBITDA rising sharply from the prior-year period as growth continued across both of…
Vertex Pharmaceuticals (NASDAQ:VRTX) Upgraded at Wall Street Zen
Vertex Pharmaceuticals (NASDAQ:VRTX - Get Free Report) was upgraded by Wall Street Zen from a 'hold' rating to a 'buy' rating in a report issued on Sunday. CRISPR Therapeutics Gains After Earnings as Pipeline Hope Grows Other research analysts have…
Altman Advisors Inc. Sells 5,338 Shares of AbbVie Inc. $ABBV
Altman Advisors Inc. trimmed its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 33.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,536 shares…
Receive a Daily briefing on Pharma Industry News
Get Started